Skip to main content

Corporate insider profile

Adam D. Levy Insider Trades

Latest reported as Chief Financial Officer of Acrivon Therapeutics, Inc. (ACRV).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,792.94
Latest transaction
Aug 4, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 4, 2026Acrivon Therapeutics, Inc. (ACRV)Chief Financial OfficerSale1,142$1.57$1,793